Drugs / MEND™ Repair and Recover®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06050668 | Jun 2024 → Jul 2026 overdue | muscular atrophy, osteoporosis | Michael C Willey | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEND Repair and Recover | “The EAA-based supplement used in this clinical trial is MEND™ Repair and Recover®.” NCT06050668 ↗ |
| Route | Oral | “essential amino acid (EAA)-based oral nutrition supplementation” NCT06050668 ↗ |